Use Of Fragmin In Hemodialysis

Last updated: January 30, 2017
Sponsor: Pfizer
Overall Status: Completed

Phase

3

Condition

Nephropathy

Kidney Disease

Kidney Failure (Pediatric)

Treatment

N/A

Clinical Study ID

NCT01879618
A6301091
  • Ages 18-85
  • All Genders

Study Summary

The study will determine if the Fragmin dose can be adjusted to suit the clinical needs of patients during dialysis.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • chronic renal failure on hemodialysis

Exclusion

Exclusion Criteria:

  • significant comorbidities that would prevent a patient from completing the trial

Study Design

Total Participants: 152
Study Start date:
October 01, 2013
Estimated Completion Date:
March 31, 2016

Connect with a study center

  • Grey Nuns Community Hospital

    Edmonton, Alberta T6L 5X8
    Canada

    Site Not Available

  • Royal Alexandra Hospital

    Edmonton, Alberta T5G 0B8
    Canada

    Site Not Available

  • University of Alberta Hospital

    Edmonton, Alberta T6G 2B7
    Canada

    Site Not Available

  • St Paul's Hospital

    Vancouver, British Columbia V6Z 1Y6
    Canada

    Site Not Available

  • Horizon Health Network/Saint John Regional Hospital

    Saint John, New Brunswick E2L 4L2
    Canada

    Site Not Available

  • Eastern Regional Health Authority, Health Sciences Centre

    St. John's, Newfoundland and Labrador A1B 3V6
    Canada

    Site Not Available

  • Eastern Regional Health Authority, St. Clare's Mercy Hospital

    St. John's, Newfoundland and Labrador A1C 5B8
    Canada

    Site Not Available

  • Eastern Regional Health Authority, Waterford Hospital

    St. John's, Newfoundland and Labrador A1E 4J8
    Canada

    Site Not Available

  • Queen Elizabeth II Health Sciences Center (QEII) - VG Site

    Halifax, Nova Scotia B3H 2Y9
    Canada

    Site Not Available

  • William Osler Health System - Bramptom Civic Hospital

    Brampton, Ontario L6R 3J7
    Canada

    Site Not Available

  • London Health Sciences Centre, Kidney Care Centre

    London, Ontario N6K 1M6
    Canada

    Site Not Available

  • London Health Sciences Centre, University Hospital

    London, Ontario N6A 5A5
    Canada

    Site Not Available

  • William Osler Health System

    Orangeville, Ontario L9W 4X9
    Canada

    Site Not Available

  • The Scarborough Hospital

    Scarborough, Ontario M1P 2V5
    Canada

    Site Not Available

  • Centre externe de néphrologie CISSS de la Montérégie-Centre

    Greenfield Park, Quebec J4V 3M3
    Canada

    Site Not Available

  • Centre intégré de santé et de services sociaux de la Montérégie-Centre

    Greenfield Park, Quebec J4V 2H1
    Canada

    Site Not Available

  • CIUSSS du Nord-de-l'Ile-de-Montreal

    Montreal, Quebec H4J 1C5
    Canada

    Site Not Available

  • Centre Hospitalier de l'Universite de Montreal (CHUM) - Hopital Saint-Luc

    Montreal, Quebec H2X 3J4
    Canada

    Site Not Available

  • Centre externe de néphrologie CISSS de la Montérégie-Centre

    Saint-Lambert, Quebec J4R 2L1
    Canada

    Site Not Available

  • CHU de Quebec (Pavillon Hotel-Dieu de Quebec)

    Quebec, G1R 2J6
    Canada

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.